Skip to main content
. 2015 Apr 16;56(4):727–734. doi: 10.1093/jrr/rrv019

Fig. 1.

Fig. 1.

The 3-year overall survival (OS), cause-specific survival (CSS), and progression-free survival (PFS) rates were 77.7%, 86.9% and 60.9%, respectively. The corresponding local control (LC) rate was 89.8%.